ResultsIQ › Latest results › Asarfi Hospital Ltd
Asarfi Hospital Ltd Q2 FY27 results deck summary
NSE: ASARFI · BSE: 543943
Results deck of 13 Nov 2026, summarised by AI from the filing.
Asarfi Hospital's Q2 FY27 consolidated revenue rose 18.1% YoY to ₹53.0 cr, with EBITDA margin at 22.4% and PAT at ₹6.1 cr.
Key takeaways
- Record quarter Consolidated revenue was ₹53.0 cr (+18.1% YoY), EBITDA ₹11.9 cr (+34.0% YoY) at a 22.4% margin, and PAT ₹6.1 cr (+45.2% YoY).
- No guidance The deck gives no forward revenue, margin or PAT guidance; the only forward item is a planned BSE SME to Main Board migration, subject to approvals.
- Specialty decline Surgical Oncology revenue declined 56% and Radiation Oncology 18% YoY, and General Surgery revenue fell 2%.
Asarfi Hospital Ltd earnings call, investor presentation and press release summaries
- Q2 FY27: Results deck (13 Nov 2026), Results press release (13 Nov 2026)
- Q1 FY27: Results deck (7 Aug 2026)
- Q4 FY26: Earnings call (27 May 2026), Results deck (11 May 2026), Results press release (11 May 2026)
- Q3 FY26: Results deck (9 Feb 2026), Results press release (9 Feb 2026)
- Q2 FY26: Earnings call (19 Nov 2025), Results deck (10 Nov 2025)
- Q1 FY26: Results deck (7 Aug 2025)
- Q4 FY25: Earnings call (12 May 2025), Results deck (8 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.